Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Belden Inc. stock logo
BDC
Belden
$83.25
-1.2%
$86.90
$60.54
$99.13
$3.38B1.04275,344 shs261,905 shs
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
$0.00
$0.28
$1.91
$4.06MN/A364,033 shs190,300 shs
Humana Inc. stock logo
HUM
Humana
$316.04
-3.6%
$329.24
$299.23
$541.21
$39.57B0.452.01 million shs3.49 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Belden Inc. stock logo
BDC
Belden
-1.25%+1.27%-9.52%+11.48%+8.09%
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
0.00%0.00%0.00%0.00%0.00%
Humana Inc. stock logo
HUM
Humana
-3.60%-2.29%-8.98%-11.16%-37.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Belden Inc. stock logo
BDC
Belden
4.812 of 5 stars
2.45.01.73.22.92.53.1
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/AN/AN/AN/AN/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
4.9983 of 5 stars
4.24.03.33.93.03.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Belden Inc. stock logo
BDC
Belden
2.80
Moderate Buy$102.2522.82% Upside
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
2.47
Hold$454.6343.85% Upside

Current Analyst Ratings

Latest BDR, BDC, NWF, and HUM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Humana Inc. stock logo
HUM
Humana
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$411.00 ➝ $381.00
4/10/2024
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$391.00
4/8/2024
Humana Inc. stock logo
HUM
Humana
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$413.00 ➝ $350.00
4/4/2024
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$391.00
4/3/2024
Humana Inc. stock logo
HUM
Humana
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$450.00 ➝ $385.00
4/2/2024
Humana Inc. stock logo
HUM
Humana
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$356.00 ➝ $310.00
4/2/2024
Humana Inc. stock logo
HUM
Humana
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$427.00 ➝ $396.00
4/2/2024
Humana Inc. stock logo
HUM
Humana
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$470.00 ➝ $342.00
3/22/2024
Humana Inc. stock logo
HUM
Humana
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
3/13/2024
Humana Inc. stock logo
HUM
Humana
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
2/9/2024
Belden Inc. stock logo
BDC
Belden
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$89.00 ➝ $98.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Belden Inc. stock logo
BDC
Belden
$2.51B1.35$9.40 per share8.86$27.98 per share2.98
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/AN/AN/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
$106.37B0.36$33.30 per share9.49$132.55 per share2.38

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Belden Inc. stock logo
BDC
Belden
$242.76M$5.6614.7111.44N/A9.66%25.11%9.31%5/2/2024 (Confirmed)
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
$2.49B$19.8215.9513.831.912.34%19.44%6.07%N/A

Latest BDR, BDC, NWF, and HUM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Belden Inc. stock logo
BDC
Belden
$1.05N/A-$1.05N/AN/AN/A  
4/24/2024Q1 24
Humana Inc. stock logo
HUM
Humana
$6.12$7.23+$1.11N/A$28.52 billion$29.61 billion      
2/8/2024Q4 2023
Belden Inc. stock logo
BDC
Belden
$1.12$1.46+$0.34$2.01$522.06 million$551.24 million    
1/25/202412/31/2023
Humana Inc. stock logo
HUM
Humana
$0.76-$0.11-$0.87$4.20$25.47 billion$26.46 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Belden Inc. stock logo
BDC
Belden
$0.200.24%N/A3.53%N/A
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/AN/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
$3.541.12%+12.29%17.86%7 Years

Latest BDR, BDC, NWF, and HUM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/18/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88501.09%6/28/20246/28/20247/26/2024
2/15/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88500.97%3/27/20243/29/20244/26/2024
2/22/2024
Belden Inc. stock logo
BDC
Belden
Quarterly$0.050.24%3/13/20243/14/20244/9/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Belden Inc. stock logo
BDC
Belden
1.03
2.30
1.72
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/AN/AN/A
Humana Inc. stock logo
HUM
Humana
0.63
1.59
1.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Belden Inc. stock logo
BDC
Belden
98.75%
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/A
Humana Inc. stock logo
HUM
Humana
92.38%

Insider Ownership

CompanyInsider Ownership
Belden Inc. stock logo
BDC
Belden
1.42%
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/A
Humana Inc. stock logo
HUM
Humana
0.29%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Belden Inc. stock logo
BDC
Belden
8,00040.66 million40.09 millionOptionable
Blonder Tongue Laboratories Inc. stock logo
BDR
Blonder Tongue Laboratories
N/A13.33 millionN/ANot Optionable
Humana Inc. stock logo
HUM
Humana
67,600120.65 million120.30 millionOptionable

BDR, BDC, NWF, and HUM Headlines

SourceHeadline
Humana Inc. (HUM) Quarterly Report: What Does It Reveal About Their Sector PerformanceHumana Inc. (HUM) Quarterly Report: What Does It Reveal About Their Sector Performance
americanbankingnews.com - April 25 at 2:10 AM
Humana targets internal cuts amid Medicare Advantage challengesHumana targets internal cuts amid Medicare Advantage challenges
modernhealthcare.com - April 25 at 2:08 AM
Humana pulls back 2025 guidance following MA rate cutHumana pulls back 2025 guidance following MA rate cut
fiercehealthcare.com - April 25 at 2:08 AM
Humana’s Buy Rating Affirmed Amidst Long-Term Growth Potential and Competitive PositioningHumana’s Buy Rating Affirmed Amidst Long-Term Growth Potential and Competitive Positioning
markets.businessinsider.com - April 25 at 2:08 AM
Humana Withdraws Its Already Lowered 2025 Profit GuidanceHumana Withdraws Its Already Lowered 2025 Profit Guidance
finance.yahoo.com - April 25 at 2:08 AM
Insurer Humana pulls 2025 profit forecast on disappointing Medicare ratesInsurer Humana pulls 2025 profit forecast on disappointing Medicare rates
msn.com - April 25 at 2:08 AM
Humana Reports $741 Million Profit And Boosts Medicare ForecastHumana Reports $741 Million Profit And Boosts Medicare Forecast
forbes.com - April 25 at 2:08 AM
Humana (NYSE:HUM) Trading Down 4.7%Humana (NYSE:HUM) Trading Down 4.7%
marketbeat.com - April 24 at 5:17 PM
Humana Shares Dip After 2025 Guidance is PulledHumana Shares Dip After 2025 Guidance is Pulled
wsj.com - April 24 at 4:06 PM
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
zacks.com - April 24 at 1:56 PM
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings BeatPremium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
zacks.com - April 24 at 1:50 PM
Humana Pulls 2025 Earnings Guidance on Slowing Government Medicare FundingHumana Pulls 2025 Earnings Guidance on Slowing Government Medicare Funding
investopedia.com - April 24 at 1:40 PM
Humana shares fall as medical insurer withdraws 2025 profit guidanceHumana shares fall as medical insurer withdraws 2025 profit guidance
proactiveinvestors.com - April 24 at 11:41 AM
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesHumana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - April 24 at 10:36 AM
Humana (NYSE:HUM) Releases FY24 Earnings GuidanceHumana (NYSE:HUM) Releases FY24 Earnings Guidance
marketbeat.com - April 24 at 9:13 AM
Humana reports big profit beat, boosts Medicare Advantage membership growth viewHumana reports big profit beat, boosts Medicare Advantage membership growth view
marketwatch.com - April 24 at 9:01 AM
Humana (NYSE:HUM) Posts  Earnings ResultsHumana (NYSE:HUM) Posts Earnings Results
marketbeat.com - April 24 at 8:52 AM
Humana (HUM) Tops Q1 Earnings and Revenue EstimatesHumana (HUM) Tops Q1 Earnings and Revenue Estimates
zacks.com - April 24 at 8:46 AM
Humana reports strong Q1 2024 results, revises full-year guidanceHumana reports strong Q1 2024 results, revises full-year guidance
invezz.com - April 24 at 7:12 AM
Humana beats first-quarter profit estimates on strength of Medicare businessHumana beats first-quarter profit estimates on strength of Medicare business
reuters.com - April 24 at 6:43 AM
Humana Reports First Quarter 2024 Financial Results; Affirms Full Year Adjusted 2024 Financial GuidanceHumana Reports First Quarter 2024 Financial Results; Affirms Full Year Adjusted 2024 Financial Guidance
businesswire.com - April 24 at 6:30 AM
Analyst: the numbers now work for a Humana merger with CignaAnalyst: the numbers now work for a Humana merger with Cigna
bizjournals.com - April 24 at 1:31 AM
Humana (NYSE:HUM) Shares Up 0.2%Humana (NYSE:HUM) Shares Up 0.2%
marketbeat.com - April 23 at 3:20 PM
Why Earnings Season Could Be Great for Humana (HUM)Why Earnings Season Could Be Great for Humana (HUM)
zacks.com - April 23 at 1:06 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Belden logo

Belden

NYSE:BDC
Belden Inc. designs, manufactures, and markets a portfolio of signal transmission solutions for mission critical applications in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It operates in two segments, Enterprise Solutions and Industrial Automation Solutions. The Enterprise Solutions segment offers copper cable and connectivity solutions, fiber cable and connectivity solutions, interconnect panels, racks and enclosures, and signal extension and matrix switching systems for use in applications, such as local area networks, data centers, access control, 5G, fiber to the home, and building automation. It also provides power, cooling, and airflow management products for mission-critical data center operations; and end-to-end fiber and copper network systems. This segment serves commercial real estate, education, financial, stadiums and venues, military installations, and broadband and wireless service providers, as well as data centers, governments, healthcare, and hospitality sectors. The Industrial Automation Solutions segment offers network infrastructure and digitization solutions; secure networks for the digitization and automation of industries and infrastructure; and products and solutions covering various aspects of data handling, including acquisition, transmission, orchestration, and management for applications in discrete automation, process automation, energy, and mass transit. It sells its products to distributors, end-users, installers, and original equipment manufacturers (OEMs). The company was formerly known as Belden CDT Inc. and changed its name to Belden Inc. in May 2007. Belden Inc. was founded in 1902 and is headquartered in Saint Louis, Missouri.
Blonder Tongue Laboratories logo

Blonder Tongue Laboratories

NYSE:BDR
Blonder Tongue Laboratories, Inc. operates as a technology development and manufacturing company, which engages in delivering television signal encoding, transcoding, digital transport, and broadband product solutions for applications. It also offers system operators and integrators serving the cable, broadcast, satellite, institutional, and professional video markets with solutions for the provision of content contribution, distribution, and video delivery to homes and businesses. The company was founded by Ben H. Tongue and Isaac S. Blonder in 1950 and is headquartered in Old Bridge, NJ.
Humana logo

Humana

NYSE:HUM
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.